SCHEMBL17326130

SCHEMBL17326130

C[Si](C)(C)OCC1O[C@H](O[Si](C)(C)C)C(O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H]1O[Si](C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2521899 1.00 — —
SCHEMBL19306301 1.00 — —
SCHEMBL2527021 1.00 — —
SCHEMBL13925626 1.00 — —
SCHEMBL14042201 0.93 HPSE (0.31) —
SCHEMBL11206262 0.89 HPSE (0.33) —
SCHEMBL14617505 0.85 — —
SCHEMBL16687811 0.84 — —
SCHEMBL9971329 0.84 — —
SCHEMBL23743606 0.82 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015187040-A1 AMINO SPHINGOGLYCOLIPID ANALOGUES ANDERSON REGAN JAMES (NZ) 2015-12-10 — — WO disclosed
Send feedback